| Sarah M Lamb, RN, CNS, MS | |
|
2 Bon Air Rd, Suite 100, Larkspur, CA 94939-1141 | |
| (415) 927-0666 | |
| (415) 927-6919 |
| Full Name | Sarah M Lamb |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist |
| Location | 2 Bon Air Rd, Larkspur, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346571312 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364S00000X | Clinical Nurse Specialist | 3126 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sarah M Lamb, RN, CNS, MS 2 Bon Air Rd, Suite 100, Larkspur, CA 94939-1141 Ph: () - | Sarah M Lamb, RN, CNS, MS 2 Bon Air Rd, Suite 100, Larkspur, CA 94939-1141 Ph: (415) 927-0666 |
News Archive
Black, Hispanic, and Native Americans constitute one-third of the U.S. population, but only 9% of practicing physicians. To address the lack of diversity and inclusion in medicine, Yale physicians conducted a study exploring the role of race and ethnicity in minority resident training experiences.
Clostridium difficile infection (CDI) treatment in a hospital setting using low dose oral vancomycin showed similar effectiveness compared to high dose, according to a new study by researchers at Montefiore Medical Center and Albert Einstein College of Medicine of Yeshiva University.
"Man-made chemicals in everyday products are likely to be at least the partial cause of a global surge in birth deformities, hormonal cancers and psychiatric diseases, a U.N.-sponsored research team reported on Tuesday," Reuters reports.
The pressures from an ageing population on the rising costs of healthcare in Australia will be the subject of the third annual Menzies Oration to be held at The Australian National University tonight.
An experimental drug aimed at treating a common liver disease showed promising results and potential problems in a multicenter clinical trial funded by the National Institutes of Health. The FLINT study found that people with nonalcoholic steatohepatitis (NASH) who took obeticholic acid (OCA) had improved liver health during that period, including decreased inflammation and fat in the liver and decreased body weight versus people receiving a placebo. OCA was also associated with increases in itching and total cholesterol.
› Verified 1 days ago
Elaine Luu, FNP, CNS, RN Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 5 Bon Air Rd Ste 150, Larkspur, CA 94939 Phone: 415-945-7800 Fax: 415-924-6607 |